Saba Capital Management, L.P. Acquires 29,795 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. bought 29,795 shares of the company’s stock in a transaction dated Wednesday, October 16th. The stock was purchased at an average price of 15.81 per share, for a total transaction of 471,058.95. Following the purchase, the insider now owns 20,750,913 shares of the company’s stock, valued at approximately 328,071,934.53. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Monday, October 14th, Saba Capital Management, L.P. acquired 15,281 shares of BlackRock Health Sciences Term Trust stock. The stock was purchased at an average price of 15.87 per share, with a total value of 242,509.47.
• On Monday, September 30th, Saba Capital Management, L.P. bought 8,012 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of 15.84 per share, with a total value of 126,910.08.
• On Friday, September 27th, Saba Capital Management, L.P. purchased 1,633 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 15.89 per share, for a total transaction of 25,948.37.
• On Wednesday, September 25th, Saba Capital Management, L.P. acquired 300 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 15.73 per share, with a total value of 4,719.00.
• On Monday, September 23rd, Saba Capital Management, L.P. bought 2,006 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 15.98 per share, for a total transaction of 32,055.88.
• On Thursday, September 19th, Saba Capital Management, L.P. purchased 15,455 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 16.14 per share, with a total value of 249,443.70.
• On Tuesday, September 17th, Saba Capital Management, L.P. acquired 27,148 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 15.93 per share, for a total transaction of 432,467.64.

BlackRock Health Sciences Term Trust Trading Up 0.2 %

Shares of BMEZ opened at 15.70 on Friday. The firm has a fifty day simple moving average of 15.87 and a two-hundred day simple moving average of 15.49. BlackRock Health Sciences Term Trust has a 1-year low of 12.93 and a 1-year high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be given a dividend of $0.176 per share. This represents a $2.11 dividend on an annualized basis and a yield of 13.45%. The ex-dividend date of this dividend is Tuesday, October 15th.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Dakota Wealth Management increased its position in shares of BlackRock Health Sciences Term Trust by 5.3% during the 2nd quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after purchasing an additional 915 shares during the last quarter. Benjamin F. Edwards & Company Inc. increased its holdings in BlackRock Health Sciences Term Trust by 21.7% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock valued at $96,000 after buying an additional 1,038 shares during the last quarter. Kingswood Wealth Advisors LLC raised its position in BlackRock Health Sciences Term Trust by 9.2% in the first quarter. Kingswood Wealth Advisors LLC now owns 21,988 shares of the company’s stock worth $360,000 after acquiring an additional 1,845 shares during the period. Comerica Bank boosted its stake in shares of BlackRock Health Sciences Term Trust by 31.1% during the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after acquiring an additional 3,671 shares during the last quarter. Finally, PNC Financial Services Group Inc. grew its position in shares of BlackRock Health Sciences Term Trust by 17.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 30,559 shares of the company’s stock valued at $448,000 after acquiring an additional 4,604 shares during the period.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.